Nanjing Shuangwei Biotechnology Co., Ltd. (hereinafter referred to as Shuangwei Biotechnology) is an innovative medical device enterprise, founded in 2001, with the two main businesses of Safe Blood Transfusion and Wound Therapy as the core, supported by the three major platforms of Sterilization Service Platform, Medical Device Agent Platform, New Material R&D And Manufacturing Platform, focusing on the research and development, production, sales and service of new disposable medical consumables.

Shuangwei Biotechnology is now a holding subsidiary of Nanjing Tongtian Technology Co., Ltd., which was established in September 2000, is a non-listed public company regulated by the CSRC. At present, the company's business mainly focuses on capital operation and holding management, directly holding shares in and controlling six subsidiary companies.

The company's products include: medical devices, non-communication optical fibers, building thermal insulation materials, glass fiber reinforced resin grinding wheels, and fund products, etc.

Research and development of new high-tech medical devices

In addition to its own investment in research and development, Shuangwei Biotechnology has fully introduced and relied on external scientific research forces. The company has established extensive cooperative relationships with many domestic universities, medical institutions such as the Jiangsu Provincial Blood Center, Nanjing Red Cross Blood Center, Institute of Transfusion Medicine, Chinese Academy of Medical Sciences, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, and the General Hospital of the Eastern Theater Command, as well as universities like Nanjing Normal University, Nanjing University of Science and Technology, and Nanjing University of Aeronautics and Astronautics. It has successfully built an integrated research, production and education platform for the research and development of medical products, and is specialized in the research and development of new high-tech medical devices.

Give full play to the expertise to provide technical support for member units

In recent years, Shuangwei Biotechnology has given full play to its role as a bridge, assisting the association in building a communication and exchange platform to promote the development of the industry. The company took the lead in establishing the Jiangsu Provincial Professional Committee of Biobased Composites and serves as the unit of the chairperson. In addition, Shuangwei Biotechnology is also a member unit of the China Transfusion Equipment Committee, a member of the China Medical Devices Industry Association, a director unit of the Medical Polymer Products Branch of the China Medical Devices Industry Association, a unit of the National Technical Committee for Standardization of Medical Infusion Sets, a director unit of the Jiangsu Provincial Blood Transfusion Association, the unit of the secretary general of the Nanjing Medical Devices Association, a standing committee member unit of the Federation of Industry and Commerce in Jiangbei New Area, Nanjing, and a director unit of the Nanjing Industrial Internet Industry Alliance. In the professional field, it gives full play to its expertise and provides technical support for member units.